View Cart (0 items)

Pharmaceutical

PCI acquires clinical trail services company Biotec

Pharmaceutical packaging services provider PCI has expanded its presence in the European Union with the acquisition of Biotec Services International.
Read More

New heart failure drug could cut deaths by 20%

Swiss pharmaceuticals group Novartis is planning to launch a new drug that has the potential to cut cardiovascular death and admissions to hospital by 20%.
Read More

Global pharmaceutical sales projected to reach $1 trillion in 2014

The outlook for the pharmaceutical industry is bright, according to a new report that identifies a number of positive trends.
Read More

FDA's regulatory policy not biased against Indian drug makers

Amid news of regulatory action taken by the U.S. watchdog against pharmaceutical companies, at first glance it would appear that mostly Indian companies have come under fire.
Read More

New FDA requirements to increase costs for Indian drug makers

The U.S. Food and Drug Administration (FDA) is introducing more stringent regulation regarding quality standards for drug products manufacturing, which will push up costs for Indian drug producers.
Read More

Canadian doctors prescribe drugs off label, putting patients at risk

An investigation by the Toronto Star suggests that a drug product prescribed to pregnant women for morning sickness may be linked to birth defects.


Read More

China arrested 186 people for environmental violations in 2013

As part of a nationwide campaign carried out in 2013 by local environmental authorities, over 3,500 businesses and workshops were closed after some 6,500 instances of environmental problems were detected.
Read More

India's drug makers embrace automation

India's second largest drug maker by sales, Dr. Reddy's Laboratories, is embracing automation and making it a critical part of the manufacturing process.
Read More

British scientists discover way to fight antibiotic-resistant bacteria

Thanks to a new study by researchers at the University of East Anglia (UEA), the fight against antibiotic-resistant bacteria may become easier.
Read More

FDA's action against Ranbaxy will cost US consumers

Indian drug-maker Ranbaxy Laboratories Ltd. was supposed to introduce three generic versions of branded products that could potentially save Americans millions of dollars, but problems related to regulation and manufacturing standards are delaying their launch.
Read More